Roche buys rights to Evotec drugs

03/10/2009 | Bloomberg

Roche Holding has acquired the rights to a depression drug being developed by German biotech firm Evotec. Roche is also buying back from Evotec the rights to the EVT 100 family of drugs, which includes drugs for Alzheimer's disease and Parkinson's disease.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC